Interstitial Lung Disease

Translational research investigating the molecular mechanisms of lung fibrosis. 

Basic research on the role of avb6 mediated TGF-b activation in pulmonary fibrosis. (Sheppard Lab)

Development of novel therapies for the treatment of idiopathic pulmonary fibrosis. (Chapman and Sheppard Lab)

Basic investigation of the molecular mechanisms of the unfolded protein response to the pathogenesis of pulmonary fibrosis. (Papa Lab)

Basic and translation studies of the mechanisms of autoimmune-mediated lung disease. (Shum Lab)

Basic and translational research on the contribution of epithelial to mesenchymal transition plays in the pathogenesis of pulmonary fibrosis. (Wolters and Chapman Lab)

Basic research directed at understanding the pathways that regulate collagen turnover in relation to fibrotic disease. Atabai Lab)

Translational research investigating molecular mechanisms of sarcoidosis. (Koth Lab)

Investigations into the genetic causes of lung fibrosis (Collard and Wolters Labs)

Basic and translational research on the contribution of macrophages to pulmonary fibrosis. (Bhattacharya and Atabai Lab)

Basic and translational research investigating the consequences of telomere dysfunction to pulmonary fibrosis. (Wolters Lab)

Kamran Atabai, MD

Harold Chapman, MD

Harold Collard, MD

Mallar Bhattacharya, MD

Jeffrey Golden, MD

Laura Koth, MD

Erica Farrand, MD

Feroz Papa, MD

Rupal Shah, MD

Dean Sheppard, MD

Anthony Shum, MD

Aida Venado, MD

Leah Witt, MD

Paul Wolters, MD